Medirom Healthcare Technologies Inc
$ 1.11
1.83%
14 Apr - close price
- Market Cap 8,613,100 USD
- Current Price $ 1.11
- High / Low $ 1.14 / 1.09
- Stock P/E 2.95
- Book Value 0.19
- EPS 0.37
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE 0.53 %
- 52 Week High 3.53
- 52 Week Low 0.60
About
MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.
Analyst Target Price
$5.12
Quarterly Earnings
| Sep 2025 | Mar 2025 | Sep 2024 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-21 | 2025-04-29 | 2024-11-07 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 |
| Reported EPS | -87.38 | 110.27 | -118.56 | -0.482 | -0.4836 | -0.1157 | -0.1133 | -0.5099 | -0.5121 | -0.0442 | -0.0444 | 0.0596 |
| Estimated EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise | -87.38 | 110.27 | -118.56 | -0.482 | -0.4836 | -0.1157 | -0.1133 | -0.5099 | -0.5121 | -0.0442 | -0.0444 | 0.0596 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MRM
2026-04-09 10:10:55
MEDIROM Healthcare Technologies (MRM) has extended the maturity date of a loan with Kufu Company Holdings Inc. to April 30, 2026, from the original March 31, 2026. This extension requires all accrued interest through March 31 to be paid immediately, and the principal plus continuing interest to be repaid by the new deadline. The move provides short-term financial flexibility but highlights ongoing liquidity concerns.
2026-04-09 04:39:05
Healthcare Technologies Inc. (MRM) and Kufu Company Holdings Inc. agreed to extend the maturity date of their Deemed Loan Agreement from March 31, 2026, to April 30, 2026. This one-month extension requires all accrued interest through March 31, 2026, to be paid, while other loan terms remain unchanged. The company incorporated this report into its existing registration statements on Form S-8 and Form F-3.
2026-03-30 15:39:58
Kufu Company Holdings, Inc. has increased its stake in Medirom Healthcare Technologies Inc. (MRM) through the purchase of JPY 275 million in Fourth Unsecured Convertible-Type Corporate Bonds. This transaction, revealed in an amended SEC filing, brings Kufu's beneficial ownership to 9.44% of Medirom's common shares on an as-converted basis. The new bonds bear 5.0% annual interest and are convertible into Medirom common shares at JPY 330 per share, with the investment held for general purposes and potential reassessment based on Medirom's performance.
2026-03-27 13:40:53
An analysis by Intellectia AI™ suggests that Medirom Healthcare Technologies Inc (MRM) is not a strong buy for long-term investors due to bearish technical indicators, including an oversold RSI and negative MACD. The stock is expected to decline further in the short term, with key support levels identified. Given the lack of positive catalysts, financial data, or significant insider activity, a "Hold" recommendation is issued.
2026-03-19 10:39:20
Medirom Healthcare Technologies Inc. director Ogawa Tomoya has filed an initial ownership report (Form 3) disclosing a direct holding of 28,500 common shares. This filing serves as a baseline disclosure of his equity stake in the company and does not indicate any recent purchases or sales. The Form 3 was filed on March 18, 2026, establishing his position as a company insider.
2026-03-19 00:09:49
This article provides details on Medirom Healthcare Technologies Inc.'s current stock price, key financial metrics, and performance over various periods. As of March 18, 2026, the stock is priced at $1.26, with a market capitalization of $9.80 million. It also includes analyst ratings and answers frequently asked questions about the company and its stock.
